These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19526212)

  • 1. Reducing glycaemic variability in type 1 diabetes self-management with a continuous glucose monitoring system based on wired enzyme technology.
    Danne T; de Valk HW; Kracht T; Walte K; Geldmacher R; Sölter L; von dem Berge W; Welsh ZK; Bugler JR; Lange K; Kordonouri O
    Diabetologia; 2009 Aug; 52(8):1496-503. PubMed ID: 19526212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
    Pickup JC; Freeman SC; Sutton AJ
    BMJ; 2011 Jul; 343():d3805. PubMed ID: 21737469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial.
    Heimbürger SMN; Hoe B; Nielsen CN; Bergmann NC; Hartmann B; Holst JJ; Vilsbøll T; Dejgaard TF; Christensen MB; Knop FK
    Diabetologia; 2021 Nov; 64(11):2425-2431. PubMed ID: 34405256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prepregnancy care in women with type 1 diabetes improves HbA
    Perea V; Giménez M; Amor AJ; Bellart J; Conget I; Vinagre I
    Diabetes Res Clin Pract; 2019 Aug; 154():75-81. PubMed ID: 31271810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.
    Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
    Diabetologia; 2018 Mar; 61(3):539-550. PubMed ID: 29273897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensor and software use for the glycaemic management of insulin-treated type 1 and type 2 diabetes patients.
    Ajjan RA; Abougila K; Bellary S; Collier A; Franke B; Jude EB; Rayman G; Robinson A; Singh BM
    Diab Vasc Dis Res; 2016 May; 13(3):211-9. PubMed ID: 27000105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS).
    New JP; Ajjan R; Pfeiffer AF; Freckmann G
    Diabet Med; 2015 May; 32(5):609-17. PubMed ID: 25661981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous glucose monitoring systems for type 1 diabetes mellitus.
    Langendam M; Luijf YM; Hooft L; Devries JH; Mudde AH; Scholten RJ
    Cochrane Database Syst Rev; 2012 Jan; 1(1):CD008101. PubMed ID: 22258980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
    Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
    Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can we monitor glycaemic variability in the clinical setting?
    Inchiostro S; Candido R; Cavalot F
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 2():13-6. PubMed ID: 24034515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.
    O'Connell MA; Donath S; O'Neal DN; Colman PG; Ambler GR; Jones TW; Davis EA; Cameron FJ
    Diabetologia; 2009 Jul; 52(7):1250-7. PubMed ID: 19396424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
    Ajjan RA; Jackson N; Thomson SA
    Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep quality and glycaemic variability in a real-life setting in adults with type 1 diabetes.
    Brandt R; Park M; Wroblewski K; Quinn L; Tasali E; Cinar A
    Diabetologia; 2021 Oct; 64(10):2159-2169. PubMed ID: 34136937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychosocial factors associated with use of continuous glucose monitoring.
    Ritholz MD; Atakov-Castillo A; Beste M; Beverly EA; Leighton A; Weinger K; Wolpert H
    Diabet Med; 2010 Sep; 27(9):1060-5. PubMed ID: 20722681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CONCEPTT: Continuous Glucose Monitoring in Women with Type 1 Diabetes in Pregnancy Trial: A multi-center, multi-national, randomized controlled trial - Study protocol.
    Feig DS; Asztalos E; Corcoy R; De Leiva A; Donovan L; Hod M; Jovanovic L; Keely E; Kollman C; McManus R; Murphy K; Ruedy K; Sanchez JJ; Tomlinson G; Murphy HR;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):167. PubMed ID: 27430714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
    Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
    Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
    Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
    Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetes.
    Kilpatrick ES; Rigby AS; Goode K; Atkin SL
    Diabetologia; 2007 Dec; 50(12):2553-61. PubMed ID: 17882397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.
    Battelino T; Phillip M; Bratina N; Nimri R; Oskarsson P; Bolinder J
    Diabetes Care; 2011 Apr; 34(4):795-800. PubMed ID: 21335621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.